MarketPeel
Insider Trading Intelligence
Pricing
…
EVP, General Counsel
Paul R. Schneider
Wed, May 13, 2026
May 13
bought
$0.00
of
ZYME
178,000
shares @ $0.00
New position
2nd largest trade (out of 2)
Trade made by an officer
Unscheduled trade
Price 14% above 200-day moving average
Small Cap stock — insider trades carry more weight
ZYME
Zymeworks Inc.
Health Care
Pharmaceuticals
1D
0.00%
1W
-6.42%
1M
+7.22%
3M
-8.31%
6M
—
1Y
—
Recent insider activity at ZYME
Jan 12
Jeffrey T. L. Smith
Sold
$211.09k
Jan 12
Kenneth Galbraith
Sold
$689.82k
Jan 12
Paul Andrew Moore
Sold
$216.76k
Jan 12
Mark Hollywood
Sold
$138.76k
Jan 5
Paul Andrew Moore
Sold
$233.13k
Jan 5
Paul Andrew Moore
Sold
$271.57k
Jan 5
Kenneth Galbraith
Sold
$568.62k
Jan 5
Kenneth Galbraith
Sold
$795.22k
Full ZYME profile →
Paul R. Schneider’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback